We are a fast-growing global pharmaceutical company that develops, manufactures and distributes generic biosimilar, and added-value medicines and New Chemical Entities and New Biological Entities to over 85 countries worldwide, helping to improve access to patients to essential vital pharmaceutical care at the point of need.

Our approach is agile and inventive. We are not afraid to find new ways of doing things; continuing to explore and deliver high-quality medicines designed to fit into patients’ lives. We invest and encourage our people to think and behave differently, to be forward-looking, and to make a difference to our patients everywhere, in essence, to make it better.

Accord’s portfolio spans across critical therapeutic fields such as oncology, cardiology, neurology, psychiatry diabetes, pain management and gastroenterology.

Visit our Accord corporate page for more information (link to: https://www.accord-healthcare.com/uk/)